Financial Impact and Taxpayer Funding
The bill will likely lead to an increase in federal spending since it requires federal insurance programs, such as Medicare and Medicaid, to cover fertility treatments if the plan also “provides coverage for obstetrical services.”
The World Health Organization estimates that one in six people experience infertility. Assuming this is true, there may be up to 9.5 million women of child-bearing age in the U.S. who may be seeking fertility treatments. At the average cost of about $40,000 to conceive via IVF, the costs to the federal government could be more than a billion dollars for federally insured women alone not counting the men who rent a womb who would be eligible for coverage under the bill.
Self-Regulation of the For-Profit Fertility Industry
According to a study published in the Houston Journal of Health Law & Policy, the multi-billion-dollar fertility industry already operates like the “wild, wild west” because of a lack of regulation. The industry is currently self-regulated by organizations such as the American Society of Reproductive Medicine (ASRM) and the Society of Assisted Reproductive Technology, whose members are part of the fertility industry. These regulators currently permit genetic testing, the creation and destruction of surplus embryos, freezing embryos indefinitely, and more.
The bill reads, “The enforcement of State health and safety law regarding medical facilities or health care providers does not constitute a violation…[if] such regulations are in accordance with widely accepted and evidence-based medical standards of care for providing fertility treatment…”
The term “widely accepted and evidence-based medical standards of care” is defined in the bill as “any medical services, procedures, and practices that are in accordance with the guidelines of the American Society for Reproductive Medicine.” Essentially, the ASRM would get to decide what the standards of care are rather than giving the states any regulatory control over the industry. The bill would likely invalidate laws in at least 11 states that regulate procedures involving embryos and surrogacy.